3.03Open4.30Pre Close104 Volume41 Open Interest109.00Strike Price31.78KTurnover63.15%IV2.53%PremiumDec 6, 2024Expiry Date0.33Intrinsic Value100Multiplier4DDays to Expiry2.75Extrinsic Value100Contract SizeAmericanOptions Type-0.5031Delta0.0565Gamma36.65Leverage Ratio-0.3849Theta-0.0057Rho-18.44Eff Leverage0.0446Vega
Novo-Nordisk A/S Stock Discussion
The Commission concluded that the notified transaction would not raise competition concerns, given that the joint ventu...
Gapping up
$Poseida Therapeutics (PSTX.US)$' stock jumped over 200%. This happened because Roche, a Swiss company, is buying Poseida for up to $1.5 billion in cash.
Shares of weight-loss drug maker $Novo-Nordisk A/S (NVO.US)$ and $Eli Lilly and Co (LLY.US)$ rose 2.1% and 4.9% respectively on Tuesday as U.S. President Jo Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid...
New Positions
$Taiwan Semiconductor (TSM.US)$ , $Broadcom (AVGO.US)$ , $Johnson & Johnson (JNJ.US)$ , $Pfizer (PFE.US)$ , $Coca-Cola (KO.US)$ , $Occidental Petroleum (OXY.US)$
Sold out Positions
$Disney (DIS.US)$
Increased Positions
$Novo-Nordisk A/S (NVO.US)$ , $AstraZeneca (AZN.US)$ , $Huntington Ingalls Industries (HII.US)$
Decreased Positions
None
loading...
No comment yet